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Endothelin-1 Stimulates the Na1/Ca21 Exchanger Reverse
Mode Through Intracellular Na1 (Na1i)–Dependent and
Na1i-Independent Pathways
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Horacio Eugenio Cingolani, Ne´stor Gustavo Pe´rez
Abstract—This study aimed to explore the signaling pathways involved in the positive inotropic effect (PIE) of low doses
of endothelin-1 (ET-1). Cat papillary muscles were used for force and intracellular Na1 concentration (Na1i)
measurements, and isolated cat ventricular myocytes for patch-clamp experiments. ET-1 (5 nmol/L) induced a PIE and
an associated increase in Na1i that were abolished by Na1/H1 exchanger (NHE) inhibition with HOE642. Reverse-mode
Na1/Ca21 exchanger (NCX) blockade with KB-R7943 reversed the ET-1–induced PIE. These results suggest that the
ET-1–induced PIE is totally attributable to the NHE-mediated Na1i increase. However, an additional direct stimulating
effect of ET-1 on NCX after the necessary increase in Na1i could occur. Thus, the ET-1–induced increase in Na1i and
contractility was compared with that induced by partial inhibition of the Na1/K1 ATPase by lowering extracellular K1
(K1o). For a given Na1i, ET-1 induced a greater PIE than low K1o. In the presence of HOE642 and after increasing
contractility and Na1i by low K1o, ET-1 induced an additional PIE that was reversed by KB-R7943 or the protein kinase
C (PKC) inhibitor chelerythrine. ET-1 increased the NCX current and negatively shifted the NCX reversal potential
(ENCX). HOE642 attenuated the increase in NCX outward current and abolished the ENCX shift. These results indicate that
whereas the NHE-mediated ET-1–induced increase in Na1i seems to be mandatory to drive NCX in reverse and enhance
contractility, Na1i-independent and PKC-dependent NCX stimulation appears to additionally contribute to the PIE.
However, it is important to stress that the latter can only occur after the primary participation of the former.
(Hypertension. 2005;45:288-293.)
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Endothelin-1 (ET-1) is a powerful inotropic agent thatinduces this effect acting through different intracellular
signaling pathways.1–4 However, at doses that increase con-
tractility by '20%, the positive inotropic effect (PIE) is
entirely attributable to activation of the reverse mode of the
Na1/Ca21 exchanger (NCX).5 This increase in contractility is
similar in magnitude to that detected during the slow force
response of myocardial stretch.6–8 A sustained increase in
intracellular Ca21 through the NCX reverse mode induced by
an increase in intracellular Na1 (Na1i) produced by the
activation of the Na1/H1 exchanger (NHE) may represent the
signaling link between this transporter and cardiac hypertro-
phy.9–11 In fact, we demonstrated recently that this mecha-
nism is responsible for the increase in contractility induced by
ET-1.5 We proposed that ET-1 activates the NHE, which
increases Na1i and shifts the NCX reversal potential (ENCX) to
a more negative voltage. These changes give more time for
NCX to operate in reverse mode during the action potential
and promote Ca21 influx to the cell, determining the increase
in force.5
It is well known that activation of protein kinase C (PKC)
is a downstream pathway of ET-1 receptor binding.4 Consis-
tently, it has been shown that PKC phosphorylates the NCX
protein after ET-1 stimulation.12 Moreover, a direct PKC-
dependent increase in the NCX current (INCX) induced by
ET-1 in guinea pig myocytes was reported previously.13
Thus, the possibility exists that a direct effect of ET-1 on
NCX could also contribute to the PIE of this peptide after
NCX is driven to the reverse mode by the mandatory increase
in Na1i produced by activation of the NHE. In other words,
the increase in Na1i could be a necessary but not exclusive
condition to mediate the ET-1–induced Ca21 influx through
the NCX reverse mode. The investigation of this hypothesis
constitutes the main purpose of the present study.
The overall results obtained herein allow us to suggest that
the cardiac NCX reverse mode is modulated by ET-1 through
2 different pathways: (1) an Na1i-dependent one, consistent
with a negative shift of ENCX after a rise in Na1i attributable to
the NHE activation; and (2) an Na1i-independent and PKC-
dependent NCX stimulation. Both pathways appear to con-
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tribute to the ET-1–induced PIE. However, the latter seems to
contribute to this effect only after primary participation of the
former, which appears to be a mandatory step.
Materials and Methods
The investigation conforms to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85-23, revised 1996).
Cat papillary muscles were used for registering developed force,
intracellular pH (pHi), and Na1i measurements, and isolated cat ventric-
ular myocytes were used for patch-clamp experiments. Na1i and pHi
were determined by epifluorescence. A detailed description of these
techniques is presented in an expanded Materials and Methods section,
available online at http://www.hypertensionaha.org.
Experimental Protocols
To analyze the above-mentioned hypothesis, 3 different experimental
approaches were assayed in the present work. (1) We compared the
increase in Na1i and force promoted by ET-1 to those induced by partial
inhibition of the Na1/K1ATPase; (2) We tested the ability of ET-1 to
induce a PIE after driving the NCX in reverse mode by increasing Na1i
through the partial inhibition of the Na1/K1 ATPase in the presence of
NHE blockade; and (3) We evaluated the effects of ET-1 on outward
INCX in the presence and absence of NHE inhibition.
Pharmacological Interventions
HOE642 (1 mmol/L) was used to inhibit the NHE, KB-R7943
(5 mmol/L), to inhibit the NCX reverse mode, and chelerythrine
(1 mmol/L), to block PKC activation.
Statistics
Data are expressed as mean6SEM. To detect significant differ-
ences, paired or unpaired t test or repeated-measures 1-way
ANOVA followed by Student Newman–Keuls as post hoc test
were used as appropriate. A P,0.05 was considered to indicate
significant differences.
Results
Figure 1 shows the effects of ET-1 (5 nmol/L) on contractile
behavior (Figure 1A and 1B), on Na1i (Figure 1C), and on pHi
(Figure 1D) of isolated cat papillary muscles. Control values for
force and Na1i across groups are shown in the table. The results
indicate that the PIE of ET-1: (1) is abolished by both, NHE-1
blockade with HOE642 (1 mmol/L) and by the inhibitor of the
NCX reverse mode, KB-R7943 (5 mmol/L); and (2) is accom-
panied by an increase in Na1i without changes in pHi. The lack
of changes in pHi after NHE activation when bicarbonate is
present in the medium has been suggested previously.5,6,14 Note
that a further increase in Na1i was detected after application of
KB-R7943, suggesting that this compound blocked the ex-
change of Na1i for extracellular Ca21.
Although these experiments are suggesting that the PIE of this
ET-1 dose is entirely attributable to stimulation of the NCX
reverse mode, the possibility exists that the compound used for
blocking this NCX operation mode would be acting on other
mechanisms. However, as shown in Figure 2, this was not the
case. We were unable to show any effect of KB-R7943
(5 mmol/L) on contractility under our control conditions (Figure
2A). These results also indicate that the NCX reverse mode does
not contribute to basal contractility. KB-R7943 even failed to
affect contractility after increasing it by enhancing extracellular
Ca21 concentration in a magnitude enough to increase developed
force by'20% (Figure 2B), which is the effect produced by the
dose of ET-1 used in the present work.
To test the possibility that in addition to the Na1i-dependent
mechanism, there is also a direct stimulatory effect of ET-1 on
NCX, pilot experiments in which an increase in Na1i promoted
by partial inhibition of the Na1/K1 ATPase with ouabain were
performed. Although no systematic studies were done to estab-
Figure 1. Effect of ET-1 on contractility and Na1i in cat papillary
muscles. A, Typical force record of an isometrically contracting cat
papillary muscle showing the PIE promoted by 5 nmol/L ET-1 and
its suppression after inhibition of the NCX reverse mode with
5 mmol/L KB-R7943. B, Averaged results of 5 experiments like
those shown in A (filled symbols) and cancellation of the ET-1–
induced PIE after inhibition of NHE with 1 mmol/L HOE642 (open
symbols; n54). C, Increase in force observed with ET-1 was
accompanied by a rise in Na1i that continued after NCX inhibition
(filled symbols). Preincubation with HOE642 prevented the increase
in developed force (DF) and Na1i, supporting the notion that NHE
activation, and thus Na1i increase, is a mandatory step to increase
force (open symbols). D, Addition of ET-1 did not produce any
change in papillary muscle pHi (n54).
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lish the relationship between the increase in Na1i and developed
force in our preparations, no consistent relationship between
both parameters was found after 1, 2, or 5 mmol/L ouabain (data
not shown). These results might be explained by nonspecific
effects of this compound15,16 or failure to select the right dose.
Then we decided to increase Na1i by partial inhibition of the
Na1/K1 ATPase by lowering extracellular K1 (K1o). Figure 3
shows that when Na1i was increased by this maneuver, the
increase in developed force showed a linear relationship with
Na1i. This increase in developed force was blunted by KB-
R7943 (5 mmol/L; Figure 3, inset), indicating that it was
attributable to activation of the NCX reverse mode. However,
when the Na1i levels were augmented by ET-1–induced activa-
tion of NHE, the increase in force lies above this relationship.
Therefore, for a given Na1i, the increase in developed force was
greater when the increase in Na1i was attributable to ET-1 than
when it was induced by low K1o. This finding suggests that ET-1
is driving the NCX in reverse mode by increasing Na1i by NHE
activation, but it also has additional effects favoring the Ca21
influx through NCX.
If ET-1 is directly stimulating NCX through a PKC path-
way,12,13 and this mechanism is inducing additional effects to
NHE activation, we should detect a further increase in developed
force at higher-than-normal Na1i and under NHE blockade.
Figure 4 shows that this was the case. After the low K1o-induced
PIE and despite the NHE inhibition, an additional increase in
force was now evident when ET-1 was added to the extracellular
solution (Figure 4A). KB-R7943 reversed both PIEs, that of low
K1o and that of ET-1, indicating that they were attributable to
activation of the NCX reverse mode. On average, ET-1 induced
an increase of developed force of 10.860.4% with respect to the
steady-state value obtained with low K1o (Figure 4B). To
confirm that this ET-1–induced PIE is Na1i independent, we
performed additional experiments in which we simultaneously
recorded force and Na1i (Figure 5). A similar pharmacological
protocol of Figure 4 was followed, but in this case, instead of
KB-R7943, the PKC inhibitor chelerythrine (1 mmol/L) was
added after the ET-1–induced PIE reached a steady-state level.
Figure 5 clearly shows that under these experimental conditions,
ET-1 produces a PIE in the absence of changes in Na1i and that
this increase in contractility is completely reversed by PKC
inhibition. These overall results indicate that ET-1 is able to
induce a PKC-dependent PIE in the presence of NHE inhibition
only after the increase in Na1i produced by low K1o, which
drives the NCX to the reverse mode. These experiments also
indicate that part of the PIE of ET-1 is Na1i independent and thus
unrelated to the change in ENCX produced by the increase in Na1i.
If there are changes induced by ET-1 occurring through the
NCX in reverse independent of the alterations in the ENCX, we
Control Values of Developed Force (DF) and Na1i of the
Different Experimental Groups
Controls DF, g/mm2 Na1i, mmol/L n
Before ET-1 3.7760.39 5.1860.29 5
Before low K1o, 1.8 mmol/L 4.3360.37 5.2561.03 4
Before low K1o, 0.9 mmol/L 4.4460.38 5.7160.80 3
HOE642 before ET-1 3.5360.50 4.6561.01 4
HOE642 before low K1o (Figure 4) 3.4961.01 3
HOE642 before low K1o (Figure 5) 3.5060.40 5.4060.28 3
Figure 2. Effect of KB-R7943 on basal contractility and after
increasing force by increasing extracellular Ca21 concentration.
Inhibition of NCX reverse mode by 5 mmol/L KB-R7943 did not
affect basal contractility (A) or an increase in force of '20%
promoted by augmentation of extracellular Ca21 to 1.9 mmol/L
(B), supporting the notion that at this concentration, KB-R7943
does not elicit nonspecific effects. DF indicates developed force.
Figure 3. Effect of increasing Na1i by partial inhibition of the
Na1/K1 ATPase on cardiac contractility. When Na1i was
increased by partial inhibition of Na1/K1 ATPase after lowering
K1o to 2 different concentrations (1.8 mmol/L, solid squares;
0.9 mmol/L, solid triangles), the increase in developed force (DF)
showed a linear relationship with Na1i (y56.5413.69x). This
increase in force may conceivably be assigned to activation of
the NCX reverse mode because it was reverted by KB-R7943
(5 mmol/L; inset). However, when Na1i levels were augmented
by ET-1–induced NHE activation, the results lie above the rela-
tionship. In other words, for a similar increase in Na1i, the
increase in force was significantly greater in the presence of
ET-1, suggesting that this peptide is driving NCX in reverse
mode not only through an NHE-mediated increase in Na1i but
also by an additional effect that favors more Ca21 influx.
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should detect changes in the INCX insensitive to NHE blockade.
Thus, we next recorded whole-cell currents evoked by depolar-
izing steps between 280 and 180 mV in 10-mV increments
from a holding potential of 240 mV. Figure 6A shows the
average current-voltage (I-V) relationship for INCX before and
after addition of ET-1 to the bath solution. A statistically
significant ET-1–induced enhancement in outward INCX was
observed at potentials higher than210 mV with 1 nmol/L ET-1
and at potentials higher than 240 mV with 10 nmol/L ET-1. A
significant increase in inward INCX was also observed at270 and
280 mV with 10 nmol/L ET-1. A linear fitting of the individual
data points of the I-V for each cell was performed to detect the
0 current level of INCX, representing ENCX, in the absence and
presence of ET-1. ET-1 dose-dependently produced a significant
ENCX negative shift (Figure 6B).
To evaluate whether the ET-1–induced ENCX negative shift
was attributable to an increase in Na1i secondary to the activa-
tion of the NHE, experiments in the presence of HOE642 were
performed. Figure 6C shows the effect of HOE642 on the
average I-V for INCX before and after the addition of ET-1 to the
bath solution. A statistically significant ET-1–induced enhance-
ment in outward INCX was observed at potentials.140 mV with
1 nmol/L ET-1 and at potentials higher than 230 mV with 10
nmol/L ET-1. A significant increase in inward INCX was also
observed at 270 and 280 mV with 10 nmol/L ET-1. HOE642
did not affect basal INCX (Figure 6A and 6C). No shift in ENCX
was observed in the presence of HOE642 (Figure 6D), indicating
that the ET-1–induced negative shift observed in the absence of
this inhibitor was attributable to the increase in Na1i generated
by activation of NHE. No significant changes in basal ENCX were
observed with the NHE inhibitor (239.265.4 and 249.565.1
in the absence [n58] and presence of HOE642 [n59],
respectively).
To further analyze the net effect of ET-1 on NCX, we
compared the relative increase in INCX induced by ET-1 in the
absence and presence of the NHE inhibitor. ET-1 induced a
greater augmentation of INCX in the absence of HOE642 than in
the presence of this NHE inhibitor (at 0 mV with 10 nmol/L
ET-1; 3.560.8- and 1.960.5-fold increase in the absence [n58]
and presence of HOE642 [n59], respectively; P,0.05). The
most likely interpretation of these results is that when the ENCX
negative shift was prevented by HOE642, stimulation of the
NCX reverse mode was limited to the direct effect of ET-1 on
NCX. On the other hand, when Na1i was allowed to rise in the
absence of NHE inhibition, both effects of ET-1 on the NCX
Figure 4. ET-1 is able to further increase force after an increase in
contractility induced by low K1o in the presence of NHE inhibition.
A, representative continuous recording of force of a papillary mus-
cle pretreated with 1 mmol/L HOE642 and exposed successively to
low K1o, 5 nmol/L ET-1, and 5 mmol/L KB-R7943. In the continu-
ous presence of HOE642 in the extracellular medium, ET-1 applied
after the increase in contractility produced by low K1o was able to
induce an additional PIE that was completely reversed by
KB-R7943. B, Averaged changes in developed force (DF) at steady
state of 3 experiments like those shown in A.
Figure 5. PKC mediates the additional increase in force promoted
by ET-1 after the increase in contractility induced by low K1o in the
presence of NHE inhibition. A, Average time course changes of
developed force (DF) in 3 muscles subjected to a similar sequence
of interventions to that shown in Figure 4A except for the addition
of the PKC inhibitor chelerythrine (Che; 1 mmol/L) instead of
KB-R7943. Once again, ET-1 applied after the increase in contrac-
tility produced by low K1o further increased force, but this time,
only this additional effect was reversed by chelerythrine, suggest-
ing a direct PKC-mediated phosphorylation effect of ET-1 on NCX.
B, Interestingly, neither the additional PIE promoted by ET-1 nor its
reversion by chelerythrine affected Na1i, giving strong support to
the notion that ET-1 exerts Na1-dependent (Figure 1) and
-independent effects on force.
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were evident: the increase in the driving force for the reverse
mode induced by the ENCX negative shift and direct stimulation
of NCX.
Discussion
We can conclude that a low dose of ET-1, equipotent to the
slow force response to myocardial stretch6–8 and to doses of
angiotensin II that promote the release of ET-1,5 increases
myocardial force by increasing Na1i through the activation of
NHE, which in turn stimulates the NCX reverse mode. In the
present work, we attempted to answer the following question:
Is this increase in Na1i the only mechanism responsible for
these mechanical changes? A simplistic approach would be
that if prevention of the increase in Na1i by blocking NHE
prevented development of the mechanical counterpart, then
the increase in Na1i is the determinant of the contractile
effect. However, the possibility that the increase in Na1i could
be a necessary but not an exclusive mechanism to induce the
Ca21 influx through the NCX in reverse should be considered.
In this regard, we are presenting evidence that although
blockade of the NCX reverse mode abolished the mechanical
counterpart manifested after a rise in Na1i, induced either by
ET-1 or by Na1/K1 ATPase inhibition, for a given increase in
Na1i, the increase in developed force was greater when
activation of the NCX reverse mode was induced by ET-1
than when the Na1/K1 ATPase was inhibited. Moreover, we
also demonstrated that in the presence of NHE inhibition,
ET-1 applied after the increase in Na1i produced by low K1o
was able to induce an additional PIE that was completely
reversed by inhibition of the NCX reverse mode.
These results strongly suggest that factors affecting the NCX
reverse mode other than the increase in Na1i and the consequent
ENCX negative shift are participating when the increase in force is
mediated by ET-1. In this regard, our electrophysiological
experiments are indicating that ET-1 is also producing a direct
stimulation of NCX. A phosphorylation of NCX by a PKC-
dependent mechanism has been proposed12,13 and might repre-
sent the subcellular pathway leading to direct stimulation of this
transporter. Consistently, we showed in the present work that
PKC mediates the Na1i-independent PIE detected in the exper-
iments in which ET-1 was applied after low K1o in the presence
of NHE inhibition. The possibility that ET-1–induced activation
of different PKC isoforms may represent a common pathway for
both, Na1i-dependent and -independent effects on NCX, consti-
tutes an interesting hypothesis that deserves further research.
Taking into account the values of the ET-1–induced ENCX
negative shift detected in the present study and considering that
Ca21o, Ca21i, and Na1o were 2 mmol/L, 200 nmol/L, and
140 mmol/L, respectively, the change in Na1i can be calculated
with the equation: ENCX53ENa22ECa, where ENa and ECa are the
equilibrium potentials for Na1 and Ca21, respectively. Thus, the
values of the estimated increase in Na1i were 1.5760.51 and
5.2261.32 mmol/L for 1 and 10 nmol/L ET-1 (n58), respec-
tively. These values are of the same order of magnitude to those
measured in the bulk of the cytosol by epifluorescence in
papillary muscles after addition of 5 nmol/L ET-1 (Figure 1C).
However, it is important to note that the increase in Na1i in the
isolated myocytes might reflect changes of this ion in a space in
which intracellular dialysis with the solution of the patch pipette
cannot maintain the Na1 concentration at a constant level.
Although it is difficult to imagine how the increase in Na1i
can only enhance the NCX reverse mode without slowing the
forward mode, we would like to call attention to the fact that the
selective inhibitor of the NCX reverse mode blunted the con-
tractile response. However, we cannot completely rule out a
contribution of a reduced forward mode of the NCX to the
increase in Ca21i.
Together, the results presented herein indicate that the cardiac
NCX reverse mode is modulated by ET-1 through 2 different
pathways: (1) a negative shift of ENCX after a rise in Na1i because
Figure 6. Effects of ET-1 on INCX in the
absence and presence of NHE inhibition. A,
ET-1 effects on average I-V relations for INCX
in the absence of HOE642 (n58). Whole-cell
currents were evoked by depolarizing pulses
from 280 to 180 mV in 10-mV increments
from a holding potential of 240 mV. Cur-
rents were recorded before (control) and
after successive addition of 1 nmol/L ET-1,
10 nmol/L ET-1, and 10 mmol/L NiCl2 in the
continuous presence of ET-1. INCX was
obtained as Ni21-sensitive currents, after
subtraction of the currents in the presence of
Ni21 to those in the absence and presence
of ET-1. B, Negative shift of the ENCX (n58)
obtained from INCX after successive addition
of 1 and 10 nmol/L ET-1 and expressed as
the difference from control (DENCX). C, ET-1
effects on average I-V relations for INCX in the
presence of 1 mmol/L HOE642 (n59). Cur-
rents were recorded in the continuous pres-
ence of HOE642 and before (control) and
after successive addition of 1 nmol/L ET-1,
10 nmol/L ET-1, and 10 mmol/L NiCl2 in the
presence of ET-1. D, DENCX (n59) obtained
from Ni21-sensitive currents after successive
addition of 1 and 10 nmol/L ET-1 in the
presence of HOE642. Asterisk indicates sta-
tistically different from control.
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of NHE activation, and (2) an increase in the turnover rate of the
NCX units induced by a PKC-dependent pathway. Both path-
ways appear to contribute to the ET-1–induced PIE. However,
the increased turnover rate seems to contribute to this effect only
after the change in ENCX produced by NHE activation, which
appears to be a necessary step. The fact that basal levels of Na1i
are increased in some myocardial diseases such as hypertro-
phy17,18 or heart failure18,19 permit the speculation that it would
not be mandatory that the aforementioned mechanisms should
take place in series. Thus, the relative contribution of these 2
pathways to the ET-1–induced increase in contractility in patho-
logical states is an interesting forthcoming perspective that
deserves future attention.
Study Limitations
The main limitations of our study rely on the comparison of
the contractile response with an increase in Na1i levels by 2
different interventions, namely ET-1 and low K1o. Although
we demonstrated that both interventions increase contractility
by NCX in reverse, and that for a given increase in Na1i, ET-1
induced a greater increase in contractility than inhibition of
the Na1/K1 ATPase, the following possibilities should be
analyzed: (1) Despite an equal Na1i in the bulk of the cytosol,
the increase of Na1i induced by ET-1 would be higher in a
fuzzy space close to NCX. However, a colocalization of NCX
and NHE,20,21 and also of NCX and the Na1/K1 ATPase,22
have been reported; (2) ET-1 could induce a greater prolon-
gation of the action potential duration (APD) than low K1o,
then the influx of Ca21 through the NCX reverse mode would
be greater than that induced by Na1/K1 ATPase inhibition.
Although the increase in APD by ET-1 has been reported,23,24
low K1o can also induce a prolongation of APD,25 and the
differences between both interventions are difficult to evalu-
ate; (3) The way selected by us to increase Na1i (low K1o), by
hyperpolarizing the cell, may promote Ca21 efflux through
the forward mode of NCX, thus reducing PIE. However, no
negative inotropic effect was observed after complete block
with KB-R7943 of the low K1o-induced PIE (Figure 3, inset);
and (4) The increase in Na1i produced by either ET-1 or
inhibition of the Na1/K1 ATPase may affect regulation of ion
channels (ie, Na1-activated K1 channels26) and alter mem-
brane potential. However, in our experiments, these potential
effects of increased Na1i unlikely influence the contractile
behavior because the PIE induced by ET-1 or Na1/K1
ATPase inhibition was completely cancelled by selective
inhibition of the NCX reverse mode.
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